Immunotherapies Could Play Role in CALR-Positive Myeloproliferative Neoplasms
Published: | Updated:
This video highlights a study that establishes mutated CALR as a myeloproliferative neoplasms–specific tumor antigen and provides a rationale for the development of immunotherapies targeting mutated CALR.
